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Study objectives: The first aim of this study was to investigate the effects of nutritional
supplementation combined with low-intensity exercise on body components, exercise toler-
ance, and health-related quality of life (HRQOL) in malnourished patients with COPD. The
second aim of this study was to examine the degree of systemic inflammation and the actual
changes in levels of systemic CRP, TNFa, IL-6 and IL-8 actual changes after a combination of
nutritional supplementation and low-intensity exercise in these patients.
Design: A prospective randomized trial.
Patients: Thirty-two moderate to severe, clinically stable malnourished COPD patients.
Methods: Patients were randomly divided into a nutritional supplementation with low-inten-
sity exercise group and a control group. Lung function, maximum inspiratory and expiratory
muscle force, the Chronic Respiratory Disease Questionnaire (CRQ), the 6-min walking distance
(6MWD), and the Borg scale were measured at baseline and were re-assessed at 3 months after
intervention. The degree of systemic inflammation and the changes in levels of systemic CRP,
TNFa, IL-6 and IL-8 were assessed before and after a combination nutritional supplementation
with low-intensity exercise.
Results: Body weight and FFM increased significantly after 12 weeks of nutritional supplemen-
tation therapy in patients with COPD. The dietary intake energy increased and theance; CRQ, Chronic Respiratory Disease Questionnaire; GOLD, global initiative for chronic obstructive
quality of life; 6MWD, 6-min walking distance; MRC, Medical Research Council; PR, pulmonary
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1884 K. Sugawara et al.REE:REEpred ratio decreased significantly in the nutrition with low-intensity exercise group.
PImax, Quadriceps muscle force and the 6-min walking distance (6MWD) increased significantly
from baseline through week 12. Health status, as assessed by CRQ, improved in the domains of
dyspnea and total sores significantly in the nutrition with low-intensity exercise group after
intervention. In this group, hsCRP, IL-6, IL-8, and TNFa, decreased significantly after interven-
tion compared with the control group.
Conclusions: The combination of nutritional supplementation with low-intensity exercise
training was successful in increasing weight and energy intake as well as exercise capacity
and health-related QOL in our patients. Moreover, REE and major inflammatory cytokines
decreased significantly after nutritional supplementation with low-intensity exercise training.
The present study results suggest a potential role for the combination of nutritional supple-
mentation and low-intensity exercise in the management of malnourished patients with COPD.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
The commonly occurring weight loss and muscle wasting in
patients with chronic obstructive pulmonary disease (COPD)
adversely affect respiratory and peripheral muscle func-
tion, exercise capacity, and health status.1e3 Weight loss
may be the result of an increased energy expenditure
unbalance caused by inadequate dietary intake.4 In addi-
tion, evidence for a relation between an enhanced systemic
inflammatory response, on the one hand, and relative
anorexia, on the other hand, has been found in patients
with COPD.4 Resting energy expenditure (REE) and total
daily energy needed for activities have been reported to be
elevated in stable COPD.6,7
Selective wasting of fat-free mass, is seen in a substan-
tial proportion of patients,8 suggesting a disturbed protein
balance. Decreased protein intake, especially during the
first days of an acute exacerbation,9 decreased protein
synthesis,10 and increased protein balance turnover11 has
been reported. Also, an enhanced systemic inflammatory
response has been described as a possible cause of
a selectively disturbed protein balance.12
Several attempts have been made to reverse weight loss
and muscle wasting in patients with COPD by instituting oral
nutritional therapy.13,14 However, a recent meta-analysis
concluded that intervention with nutritional supplementa-
tion alone has no effect on improving anthropometric
measures, lung function, or functional exercise
capacity.15,16 A systematic review by Puhan et al.17 also
suggested that there was insufficient evidence for addi-
tional benefits of nutritional support.
It can be deduced from these evidences regarding
protein balance disturbances that nutritional therapy in
COPD must consist of both sufficient dietary protein and
anti-inflammatory ingredients must be combined with an
anabolic stimulus such as exercise training to enhance
improvements in muscle mass and physiologic function.
The first aim of the present study was to investigate the
effects of oral nutritional supplementation therapy, which
has anti-inflammatory effects, incorporated into a 12-week
home-based pulmonary rehabilitation program on body
composition, muscle function, exercise capacity, and
health status in depleted or weight-losing patients with
COPD. There is also no information as to whethercombination nutritional supplementation and low-intensity
exercise in patients with COPD can affect the systemic
inflammation. Therefore, the second aim of this study was
to examine the degree of systemic inflammation and actual
changes in the levels of systemic CRP, TNFa, IL-6, and IL-8
actual changes after a combination of nutritional supple-
mentation and low-intensity exercise in patients with
COPD.
Materials and methods
Subjects
Thirty-two patients with COPD were enrolled in the study
between June 2007 and September 2008 according to the
following inclusion criteria: (1) clinical diagnosis of
moderate to severe COPD, (2) a clinically stable condition
without recent exacerbations, and (3) the absence of
significant associated medical problems that might inter-
fere with the patient’s ability to undergo PR. Patients who
could not visit our hospital every 2 weeks were excluded.
No patients were receiving oxygen inhalation at the time of
this study. The Medical Research Council (MRC) dyspnea
score18 was grade 2 in 9 patients, grade 3 in 19 patients and
grade 4 in 4 patients.
The patients were included if they fulfilled the criteria
for COPD according to the American Thoracic Society
(ATS) guidelines.19 Force expiratory volume in 1 s (FEV1)
had to be less than 70% of the reference value, and the
increase in FEV1 after inhalation of a b2-agonist had to be
less than 10% of the reference value. Patients with
concomitant confounding disease such as malignant
disorders, gastrointestinal abnormalities, recent surgery,
or severe endocrine disorders were excluded. Only
patients in clinically stable condition (not suffering from
a recent respiratory tract infection) were included in the
study. Eligibility for nutritional supplementation was
defined as a body mass index (BMI; body weight/height
squared) of less than 19 kg/m2. This study was approved
by the medical ethical committee of our hospital and the
Akita University School of Health Sciences, and all
subjects provided informed consent. All procedures were
performed according to the research ethics guidelines of
the Declaration of Helsinki.20
Effects of nutritional supplementation 1885Assessments
Energy balance
REE was measured in early in the morning by an open-circuit
indirect calorimetry system using a fitting mask (Metavine;
Vain, Inc, Tokyo, Japan).21 The system was calibrated daily
before the start of the experiment. Patients were in a fasting
state for at least 10 h and had a bedrest period of at least
30 min before measurement. Patients received their main-
tenance medications 2 h before measurements started. REE
was measured when subjects were comfortably lying on
a bed in the supine position. REE was calculated from oxygen
consumption and carbon dioxide production with an abbre-
viated Weir formula.22
Before and during the last week of nutritional therapy,
patients were asked to register their food intakes over 3
consecutive days in order to assess dietary intake. The
obtained information was coded for computer nutrient
analysis. The nutrient data base was derived from the
Standard Tables of Food Composition (The Science and
Technology Agency of Japan, 1982). Dietary intake was
calculated by taking the average intake over 3 d. The use of
dietary records provides a good representation of the
actual food consumption because food intake is averaged
over 3 consecutive days, so day-to-day variations are
largely discarded.21 Total protein, carbohydrate, and fat
intake are presented as percentages of total energy intake.
The total protein intake is also expressed as grams per
kilogram of bodyweight every 24 h.
Collection and analysis of laboratory parameters
High-sensitivity serum CRP levels were assessed by latex
turbidimetric immunoassay (Nittobo Medical; Tokyo,
Japan). The analytical sensitivity of this CRP assay is
0.1 mg/L. Serum TNFa and IL-6, IL-8, leptin and ghrelin
were measured using commercially available enzyme-
linked immunosorbent assay kits (SRL, Inc; Tokyo, Japan).
At the time of the collection of venous blood samples, an
arterial blood sample was obtained by puncture of the
radial artery for blood gas analysis.
Exercise performance and health status
To measure exercise performance, patients performed in
a corridor walk for 6 min according to the ATS guidelines.23
The distance walked in 6 min (6MWD) and the dyspnea scale
was used in the analysis. Patients were not encouraged
during the walk.23
The disease specific health status was measured using
the Japanese version of the Chronic Respiratory Disease
Questionnaire (CRQ).24 The questionnaire scores four
domains e dyspnea, fatigue, emotion and mastery. It
contains 123 items, of which 62 deal primarily with physical
function and 61 with emotional function. The results are
presented as mean scores per question in each dimension.
The threshold for clinically significant change for each
dimension has been previously identified as 0.5.25Intervention protocol
All patients were randomly classified into two groups:
a nutrition with low-intensity exercise group and a controlgroup. In the nutrition with low-intensity exercise group,
patients received nutritional support of 400 kilocalories per
day for 12 weeks. Two 200 ml packages of nutritional drink
consisted of 60% energy from carbohydrates, 25% energy
from fat, and 15% energy from protein. This drink contains
omega-3 PUFAs 0.6 g and vitamins A 248 mg in total ingre-
dients. Patients were encouraged to continue the
consumption of their regular meal portions. In the control
group, patients underwent a monthly 45-min education
program including lectures on respiratory disease, control
of dyspnea, medication and equipment use, nutrition,
stress management, and relaxation techniques once every 4
weeks. All patients received anticholinergic or b2-agonist
as bronchodilators. Six patients received inhaled cortico-
steroids and three received theophylline. These mainte-
nance medications remained unchanged during the study.
Low-intensity exercise program
A multidisciplinary home-based low-intensity program26
was used in the present study. Briefly, breathing retrain-
ing consisted of pursed-lip breathing, diaphragmatic
breathing, and slow deep breathing, both in the supine and
sitting position. Exercise training included upper and lower
and lower limb exercises, respiratory muscle stretching
calisthenics,27 level walking at least 15 min, inspiratory and
expiratory muscle exercises using Threshold (HealthScan
Products Inc., Cedar Grove, NJ) set at a training intensity of
20e30% of the maximal inspiratory (PImax) and expiratory
(PEmax) muscle forces. Patients also underwent a monthly
45-min education program including lectures and discus-
sions on respiratory disease, control of dyspnea, medica-
tion and equipment use, nutrition, stress management,
relaxation techniques, home exercises and the benefits of
PR. Patients were strongly instructed to practice this
program daily at home and were supervised by a respiratory
therapist every 2 weeks in our hospital. A nurse periodically
visited each patient at home and provided information
regarding the role of the PR program. Relaxation and stair-
climbing exercises were also carried out under the super-
vision of the respiratory therapist when the patients visited
the hospital. The overall training intensity was set at
40e50% of the maximum oxygen consumption.26,28
Results
Table 1 lists the baseline parameters of the study group. As
expected, lung function was severely impaired with the
reference values. Mean arterial blood gases were normal.
No baseline differences between the nutrition with exer-
cise group and the control group were seen with regards to
age, FEV1, vital capacity, carbon dioxide tension, BMI,
arterial oxygen tension and 6MWD (Table 1).
Body weight, %IBW and FFM increased significantly after
12 weeks of nutritional supplementation therapy (Table 2).
The dietary Intake Energy increased and the REE:REEpred
ratio decreased significantly in the nutrition with low-
intensity exercise group compared with the control group
(Table 2).
PImax, Quadriceps muscle force, WBI, and 6MWD
increased significantly from baseline through week 12 in the
Table 1 Characteristics of patients with COPD.
Valuables Nutrition þ
Exercise group (n Z 17)
Control group (n Z 15) P value
Age 77.3  7.0 78.2  6.6 ns
Height, cm 160  7.1 158  7.9 ns
Weight, kg 46.5  5.2 47.1  5.8 ns
BMI 18.0  1.2 18.6  1.3 ns
Smoking, pack-year 72.8  32.2 72.0  30.2 ns
MRC dyspnea scale 2.6  1.0 2.7  1.2 ns
FEV1, L 1.23  0.63 1.27  0.63 ns
FEV1%pred, % 53.3  25.9 58.1  26.2 ns
FVC, L 2.81  0.73 2.74  0.83 ns
FEV1/FVC, % 42.8  15.8 45.0  14.3 ns
TLC, L 6.06  1.00 5.91  0.93 ns
FRC, L s4.25  0.90 4.04  0.80 ns
RV, L 3.02  0.87 3.02  0.77 ns
DLco, ml/Torr/min 9.31  4.22 9.61  4.26 ns
PaO2, Torr 78.1  5.7 75.5  9.4 ns
PaCO2, Torr 42.3  6.1 44.7  6.9 ns
PImax, cmH2O 53  26 53  24 ns
PEmax, cmH2O 86  31 79  25 ns
6MWD, m 373  153 383  156 ns
Abbreviation; BMI; Body Mass Index, MRC; Medical Research Council, FEV1; Forced Volume in 1 s, FVC; Forced Vital Capacity, TLC; Total
Lung Capacity, FRC; Functional Residual Capacity, RV; Residual Capacity, PImax; Maximum Inspiratory Pressure, PEmax; Maximum Expi-
ratory Pressure, 6MWD; 6-min walking distance.
Table 2 Changes of body composition, muscle force, HRQOL and biomarkers.
Nutrition þ Exercise group (n Z 17) Control group (n Z 15) Significant
difference
Baseline 12 weeks D ratio, % Baseline 12 weeks D ratio, % P value
Weight, kg 46.5  5.2 47.9  5.4 3.1  3.6 47.1  5.8 46.5  5.9 1.1  2.9 0.0015
%IBW, % 81.8  5.3 84.4  6.5 3.1  3.7 84.8  6.0 84.0  6.4 0.5  2.3 0.0023
Energy Intake, %pred 81.2  20.6 91.1  19.8 13.8  14.6 92.0  18.9 86.7  13.9 7.8  12.2 0.0004
REE, kcal 1418  186 1355  171 2.5  7.8 1385  207 1436  223 3.6  2.4 0.0116
REE/REEpred, 1.44  0.26 1.18  0.50 4.4  7.4 1.40  0.24 1.47  0.27 4.6  3.1 0.0006
FMI, kg/m2 4.04  0.85 4.00  1.46 4.5  11.6 4.38  1.22 4.21  1.21 4.0  8.0 0.0376
FFMI, kg/m2 14.0  0.8 14.3  1.0 2.4  3.9 14.3  1.16 14.3  1.19 0.3  2.0 0.0159
PImax, cmH2O 53.4  26.2 58.7  27.0 12.3  23.0 53.0  24.3 44.5  20.3 12.6  16.1 0.0025
Quadriceps force, kg 23.9  8.1 28.9  10.8 20.9  20.5 23.4  9.0 22.8  10.6 3.8  19.1 0.0022
WBI, kg/kg 0.52  0.17 0.60  0.21 17.2  19.3 0.50  0.18 0.49  0.19 2.8  19.5 0.0091
6MWD, m 373  153 397  153 8.7  12.5 383  155 342  158 8.8  14.4 0.0014
CRQ (HRQOL)
Total 105  24 108  22 3.6  7.1 114  24 113  24 0.9  3.1 0.0284
Dyspnea 23.4  7.5 25.5  6.2 13.7  20.6 26.5  6.6 26.0  7.6 2.6  15.8 0.0238
Fatigue 20.4  5.6 19.4  5.2 3.5  12.6 20.9  6.0 20.5  6.4 2.6  9.8 ns
Emotional function 39.0  8.6 41.2  8.1 6.4  11.1 42.6  7.9 42.6  7.3 0.4  5.1 ns
Mastery 22.4  4.7 22.4  5.0 0.17  10.4 23.7  5.1 23.8  4.6 1.5  8.2 ns
hsCRP, mg/l 1.73  1.61 1.23  1.26 26.7  27. 1.67  1.54 2.02  1.66 79.4. 270.8 0.0035
IL-6, pg/ml 2.26  1.16 2.04  1.02 5.6  37.2 2.51  1.03 3.63  2.04 50.6  55.8 0.0173
IL-8, pg/ml 4.04  2.29 2.20  0.48 31.2  29.0 2.69  1.30 4.26  2.27 71.3  99.6 0.0005
TNFa, pg/ml 2.95  2.52 2.29  1.77 8.5  26.6 3.39  2.26 4.20  2.67 57.2  137.3 0.0037
Leptin, ng/ml 2.32  1.56 2.42  1.52 6.1  15.0 2.66  1.73 2.37  1.36 1.2  15.1 ns
Ghrelin, fmol/ml 161  134 146  102 11.9  82.5 163  116 181  141 44.8  88.7 ns
Albumin, g/dl 3.99  0.53 4.09  0.33 3.5  9.6 3.96  0.63 4.01  0.62 4.0  28.9 ns
Transferrin, mg/dl 233  27 232  40 2.6  9.0 238  44 236  28 3.0  7.9 ns
Abbreviation; IBW; Ideal Body Weight, REE; Resting Energy Expenditure, FMI; Fat Mass Index, FFMI; Free Fat Mass Index, WBI; Weight
Bearing Index, 6MWD; 6-min walking distance, CRQ; Chronic Respiratory Disease Questionnaire.
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Effects of nutritional supplementation 1887nutrition with low-intensity exercise group compared with
the control group (Table 2).
Health status, as assessed by the chronic respiratory
questionnaire, improved significantly in the domains of
dyspnea and total scores in the nutrition with exercise
group after intervention in the nutrition with low-intensity
exercise group compared with the control group (Table 2).
In the nutrition with low-intensity exercise group, hsCRP,
IL-6, IL-8, andTNFadecreased significantly after intervention
compared with the control group. Ghrelin, leptin, albumin
and transferrin did not change significantly after intervention
in the nutrition with low-intensity exercise group.Discussion
We report herein the results of a pilot study of a combination
of nutritional support and home-based low-intensity exer-
cise inmalnourished patientswith COPD. The combination of
nutritional supplementation with low-intensity exercise
training was successful in increasing weight and energy
intake as well as and also in exercise capacity and health-
related QOL in our patients. Moreover, REE and major
inflammatory cytokines decreased significantly after nutri-
tional supplementation with low-intensity exercise training.
This study suggests that there is a potential role for the
combination of nutritional support and low-intensity exer-
cise in themanagement ofmalnourishedpatientswith COPD.
Our data demonstrate that REE/REEpred increased to
approximately 140% in both the nutrition with low-intensity
exercise group and the control group in malnourished COPD
patients. These marked increases in REE in patients with
malnourished COPD are in line with previous studies.29,30
The high metabolic rate seen in malnourished COPD leads
to an increase in respiratory muscle work, since the energy
cost of increasing ventilation is higher in patients with
malnourished patients with COPD than in healthy controls
of compatible age and sex.31 It has recently been reported
that underweight COPD patients show signs of an exagger-
ated systemic inflammatory response attributed to an
increase in REE, appetite suppression, and progress
cachexia.5,32 Indeed, COPD is characterized by a specific
pattern of inflammation involving neutrophils, macro-
phages, and lymphocytes.33 These cells release inflamma-
tory mediators such as IL-6, IL-8, and TNFa and interact
with structural cells in both the lung and airway.34 Our data
demonstrate significant increases in the levels of IL-6, and
IL-8 in patients with malnourished COPD, and these data
are in line with previous studies.33,34 We have shown that
the levels of elevated inflammatory cytokines decreased
significantly after intervention with the nutrition combined
with the low-intensity exercise group in this study. Human
skeletal muscle has been shown to be one of the main
sources of IL-6, and muscle-derived IL-6 stimulates CRP
production in the liver.35,36 It has recently been shown that
exercise-induced muscle-derived IL-6 is reduced after low-
intensity endurance training.37 Taken these together, our
data showing that inhibition of IL-6 and CRP, after 3-month
rehabilitation with nutritional support and low-intensity
exercise training suggest that inhibition might have
occurred, at least in part, in the skeletal muscle, not in lung
or airway.Recently the effects of nutritional support with an
omega-3 polyunsaturated fatty acid (PUFA) diet have been
reported in two studies.38,39 Matsuyama et al.38 have
reported that the effectiveness of nutritional support with
PUFA improves exercised capacity and decreases in
inflammatory cytokine levels in both in the sputum and
serum in patients with COPD. Whereas Broekhuizen et al.39
have shown that the positive effects of nutritional support
with PUFA on exercise capacity cannot be attributed to
decreased systemic levels of inflammatory cytokines. We
have hypothesized here that the combination of an omega-
3 polyunsaturated fatty acid diet and low-intensity exercise
might be more effective in increasing exercise capacity and
can also inhibit systemic inflammation in COPD. We there-
fore adopted a new approach to pulmonary rehabilitation
with nutritional supplementation that includes an omega-3
PUFA-rich diet and low-intensity exercise. Indeed, the
combination of nutritional supplementation with low-
intensity exercise training in the present study was
successful in increasing in exercise capacity and health-
related QOL accompanied by a reduction in the inflamma-
tory cytokines in this study.
Our results also demonstrate marked differences in the
pattern of weight change in the control group, whereas
those in the combination group gained weight. Notably,
these changes in weight were due to alterations in lean
mass rather than fat. Lean mass appeared to increase
significantly in the combination group, while in the control
group it was unchanged. While loss of lean or fat-free mass
may be considered to be more relevant to function in COPD,
lean mass depletion may not simply be the result of energy
imbalance but may reflect disordered protein metabolism
due to other factors such as muscle disuse, hypoxia, or drug
treatment.40 Many of these factors have not been
addressed by rehabilitation and supplementation.5,40 While
muscle mass can be increased by strength training, this
would also be expected from a training program with
nutritional support and low-intensity training program such
as ours.
These findings also suggest that our low-intensity exer-
cise training does not result in a negative energy balance in
many patients, as this issue is overcome by supplementa-
tion. Exercise in physical activity imposes a high energy
cost for patients with COPD.41 The increase in exercise
capacity for many patients who attend rehabilitation is
substantial, and dietary calorie intake may be sufficient to
meet this metabolic demand. Nutritional supplementation
might therefore confer a performance advantage by
allowing greater adherence to an exercise training
program.
Our data is in line with the data by Steiner et al.42 showing
that increases in walking performance are related to
increases in carbohydrate ingestion. An improvement in
performance from carbohydrate supplementation is biolog-
ically plausible. Carbohydrates are an important source of
energy for endurance exercise but intramuscular stores are
limited.42 Carbohydrate feeding can prolong endurance in
healthy subjects and there is evidence that a high carbohy-
drate diet can enhance the effects of endurance training.43
Muscle glycogen stores may be lower in COPD patients44
and like other deconditioned individuals, they are likely to
be highly reliant on carbohydrate as a source of fuel for
1888 K. Sugawara et al.muscular contraction.45 If physical activity increases,
carbohydrate availabilitymay becomean important factor in
sustaining exercise.
In this study, we used nutritional drink supplement for
nutritional intervention. Two 200 ml packages of nutritional
drink cost about 4.4 dollars (3.2 Euro). Total cost for 12
week nutritional support in this study was about 370 dollars
(270 Euro) per a patient. Therefore, it was suggested that
cost-effectiveness of this intervention was efficient and
that nutritional support in this study was able to be applied
to malnourished COPD patients in clinical practice.
Pulmonary rehabilitation has been established as an
effective treatment for enhancing performance in COPD.
The long-term aim of rehabilitation is the maintenance of
physical fitness through a more active lifestyle. The impli-
cation of our study is that, for some patients, this lifestyle
change can also result in a negative energy balance and
progressive weight loss. The sample size and the time
period used in our study were insufficient for reaching
a definitive conclusion. We believe that a study on a larger
scale and for a longer period of time should be conducted
to assess the effectiveness of nutritional supplementation
with low-intensity exercise during rehabilitation in under-
weight patients with COPD.
In conclusion, our data suggest a potential role for the
combination of nutritional support and low-intensity exer-
cise, and that this combination may improve the outcomes
of exercise tolerance and health-related QOL in patients
with malnourished COPD. Thus a combination of nutritional
support and low-intensity exercise may provide a new
therapeutic approach for pulmonary cachexia.Acknowledgment
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